GlassScriptPhysician profile
Vishwaradh Reddy
NPI 1811457666
$2,876.25
in general payments reported to CMS, 2019-2025
15 companies · $1,696 in 2025
The $1,696 reported for 2025 was more than what 86% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $99.99 · 2021: $854 · 2023: $203 · 2024: $23.23 · 2025: $1,696.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $853.66 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $378.06 | 2025 | Xdemvy |
| Glaukos Corporation | $281.81 | 2023-2025 | Idosetr |
| Alcon Vision LLC | $265.47 | 2025 | Clareon Panoptix Pro, Clareon |
| Rxsight INC | $229.63 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $213.67 | 2025 | Tecnis Iol, Tecnis Iol |
| New World Medical,INC. | $139.94 | 2023 | |
| Bausch & Lomb Americas INC. | $125.00 | 2025 | Miebo, Xiidra |
| Allergan, INC. | $99.99 | 2020 | |
| Nova Eye, INC. | $86.70 | 2025 | |
| Sight Sciences, INC. | $74.28 | 2024-2025 | Omni Surgical System, Tearcare System |
| Abbvie INC. | $48.83 | 2025 | |
| Dompe US, INC. | $34.34 | 2025 | Oxervate |
| Biotissue Holdings INC. | $26.76 | 2025 | |
| Sun Pharmaceutical Industries INC. | $18.11 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishwaradh Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.